ORIGINAL RESEARCH article

Front. Microbiol., 20 February 2020

Sec. Microbial Symbioses

Volume 11 - 2020 | https://doi.org/10.3389/fmicb.2020.00202

Full Transcriptomic Response of Pseudomonas aeruginosa to an Inulin-Derived Fructooligosaccharide

  • 1. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Department of Pharmacology, School of Pharmacy, University of Granada, Granada, Spain

  • 2. Department of Microbiology, Instituto de Hortofruticultura Subtropical y Mediterránea “La Mayora”, University of Málaga, Málaga, Spain

  • 3. Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR, United States

  • 4. Department of Biochemistry and Molecular Biology II, School of Pharmacy, University of Granada, Granada, Spain

  • 5. Department of Environmental Protection, Estación Experimental del Zaidín, Consejo Superior de Investigaciones Científicas, Granada, Spain

Abstract

Pseudomonas aeruginosa is an ubiquitous gram-negative opportunistic human pathogen which is not considered part of the human commensal gut microbiota. However, depletion of the intestinal microbiota (Dysbiosis) following antibiotic treatment facilitates the colonization of the intestinal tract by Multidrug-Resistant P. aeruginosa. One possible strategy is based on the use of functional foods with prebiotic activity. The bifidogenic effect of the prebiotic inulin and its hydrolyzed form (fructooligosaccharide: FOS) is well established since they promote the growth of specific beneficial (probiotic) gut bacteria such as bifidobacteria. Previous studies of the opportunistic nosocomial pathogen Pseudomonas aeruginosa PAO1 have shown that inulin and to a greater extent FOS reduce growth and biofilm formation, which was found to be due to a decrease in motility and exotoxin secretion. However, the transcriptional basis for these phenotypic alterations remains unclear. To address this question we conducted RNA-sequence analysis. Changes in the transcript level induced by inulin and FOS were similar, but a set of transcript levels were increased in response to inulin and reduced in the presence of FOS. In the presence of inulin or FOS, 260 and 217 transcript levels, respectively, were altered compared to the control to which no polysaccharide was added. Importantly, changes in transcript levels of 57 and 83 genes were found to be specific for either inulin or FOS, respectively, indicating that both compounds trigger different changes. Gene pathway analyses of differentially expressed genes (DEG) revealed a specific FOS-mediated reduction in transcript levels of genes that participate in several canonical pathways involved in metabolism and growth, motility, biofilm formation, β-lactamase resistance, and in the modulation of type III and VI secretion systems; results that have been partially verified by real time quantitative PCR measurements. Moreover, we have identified a genomic island formed by a cluster of 15 genes, encoding uncharacterized proteins, which were repressed in the presence of FOS. The analysis of isogenic mutants has shown that genes of this genomic island encode proteins involved in growth, biofilm formation and motility. These results indicate that FOS selectively modulates bacterial pathogenicity by interfering with different signaling pathways.

Introduction

The human pathogen Pseudomonas aeruginosa causes a wide array of life-threatening acute and chronic infections, particularly in immunocompromised, cancer, burn wound, and cystic fibrosis patients (Juhas, 2015). This bacterium is moreover one of the leading causes of nosocomial infections affecting hospitalized patients (Buhl et al., 2015) and mortality associated with hospital-acquired P. aeruginosa infectious like ventilator-associated pneumonia or bacteremia is above 35% (Lynch et al., 2017).

Moreover, under continuous antibiotic treatment the intestinal microbiota integrity is compromised and bears depletion of the intestinal microbiota (Dysbiosis), hence, physiological colonization resistance subsequently facilitates the establishment of the Pseudomonas aeruginosa in the intestinal ecosystem which might be considered an important internal source for P. aeruginosa infection (Ohara and Itoh, 2003; Von Klitzing et al., 2017). It is important to note that pathological alterations of the intestinal microbiota (dysbiosis) is related with continuous antibiotic treatment, obesity, diabetes and fatty liver, and of course alterations of the intestinal barrier function (IBF) as in inflammatory bowel disease and metabolic syndrome (Cano et al., 2013; Miura and Ohnishi, 2014).

The severity and permanence of these infections are related to the ability of P. aeruginosa to resist the effect of antibiotics through the formation of biofilms (Mah et al., 2003; Hoiby et al., 2010; Taylor et al., 2014). Important research efforts have been made to study the molecular mechanisms related to the formation maturation and subsequent dispersion of the biofilm (Stoodley et al., 2002; Flemming et al., 2007). A number of surface proteins and appendages, including flagella and type IV pili, were found to be associated with biofilm formation (Klausen et al., 2003; Anyan et al., 2014). Furthermore, this species is characterized by its ability to synthesize the virulent factors exotoxin A and pyocyanin (Ortiz-Castro et al., 2014) that block protein synthesis consequently leading to cell death (Gaines et al., 2007).

Treatment of P. aeruginosa infections can be particularly challenging because this bacterium is intrinsically resistant to multiple antibiotics and can easily acquire new resistances (Breidenstein et al., 2011). In fact, over the past three decades, antibiotic resistance among P. aeruginosa has escalated globally, via the global dissemination of several multidrug-resistant epidemic clones (Miyoshi-Akiyama et al., 2017). Pseudomonas aeruginosa infections thus represent a severe threat to human health worldwide and the World Health Organization has declared this bacterium the second priority pathogen for research and development of new strategies to fight it (WHO, 2017).

Besides conventional treatments, one possible strategy is based on the use of functional foods with prebiotic activity which are non-digestible foods (mostly oligosaccharides) that selectively stimulate the growth of a limited number of host-friendly colonic bacteria (Froebel et al., 2019). Thus, from a chemical standpoint, resistance to human digestive enzymes and low absorption are key for these compounds to reach the distal parts of the gut, where they can be fermented by the microbiota, which in turn is selectively modified in the process. These additional actions of prebiotics tend to enhance the capacity of the mucosa to contain luminal microorganisms and their components, i.e., intestinal barrier function (IBF). Normally, passage of microorganisms and/or their components such as Lipopolysaccharides (LPS) to the mucosa and from there to the bloodstream (translocation) is minimal, and the immune system develops tolerance to the microbiota, without inflammation. Conversely, when IBF is compromised translocation ensues, depending on the nature of the dysfunction and the physiological/pathological context. Therefore, inflammation of the intestine is considered to stem from augmented translocation, which engages the adaptive immune system, ultimately resulting in uncontrolled inflammation. Thus, reinforcing IBF may be protective and is viewed as therapeutic in this context (Natividad and Verdu, 2012; Duseja and Chawla, 2014).

A significant number of natural compounds have been found to inhibit bacterial growth, although their mechanisms of action frequently remain unclear (Amer et al., 2010). Fructooligosaccharides (FOS) are short-chain oligosaccharides that are generated by hydrolysis of the polysaccharide inulin, which is composed of two to 60 fructose monomers. Inulin is found in different nutrients such as wheat, onion, garlic and banana (Lattimer and Haub, 2010) and is the most common used fiber in prebiotics that, when used in combination with other probiotics, is able to promote the growth of specific beneficial gut bacteria such as bifidobacteria (Gibson et al., 1995; Bosscher et al., 2006).

A number of studies illustrate that FOS and inulin exert a number of different effects on humans and animals. For example, most oraly delivered plant substrate supplements that prevent gastrointestinal infections such as prebiotinTM and symbioramTM contain inulin and FOS, indicating that these compounds are also able to reduce bacterial infection. Moreover, oligosaccharids and in particular inulin and FOS were found to have beneficial effects on intestinal immunity and intestinal barrier function (IBF) (Capitán-Cañadas et al., 2013, 2016). Another study has shown that oligosaccharides from goats milk as well as galactooligosaccharides, modulate cytokine production by intestinal epithelial cells and monocytes via a mechanism involving Toll-like receptor 4 (TLR4) (Capitán-Cañadas et al., 2013). TLRs are located on the cell membrane and in endosomes, where they recognize components of cell membranes (TLR2/6, TLR2/TLR4), nucleic acids (TLR3, 7, 8, and 9) and flagellin (TLR5). TLR4 is one of the non-pathogen recognition receptors (PRRs), which are key elements in the communication between the host and the microbiota (Sánchez de Medina et al., 2013). However, further clinical oral applications will require studies on the potential effects of these natural substrates on the human body, which corresponds to the research need addressed in this article.

In addition to the bacterial growth promoting role of inulin and FOS, we reported that FOS inhibited bacterial growth and biofilm formation of P. aeruginosa PAO1 (Ortega-González et al., 2014). Additionally, both compounds caused opposing effects on bacterial motility. While FOS inhibited motility, an increased motility was observed in the presence of inulin. Moreover, in co-cultures with eukaryotic cells (macrophages) FOS, and to a lesser extent inulin, reduced the secretion of the inflammatory cytokines IL-6, IL-10, and TNF-α. We were also able to show that the reduction in cytokine secretion is due to a FOS-mediated modulation of the NF-κβ signal transduction pathway (Ortega-González et al., 2014). To gain insight into the detailed molecular processes triggered by FOS and inulin, we report here results from RNA-seq studies.

Materials and Methods

Materials

Inulin and FOS were purchased from BENEO-Orafti (Tienen Belgium). Stock solutions at 200 g/L in modified M9 minimal medium were sterilized using 0.22 μm cut-off filters and aliquots were stored at −20°C.

Culture and Growth Conditions

Pseudomonas aeruginosa PAO1 was grown overnight at 37°C in minimum M9 medium. The resulting cultures were then used to inoculate 50 ml of minimum M9 medium supplemented by 5 mM of citrate (MM9) (in 250 ml Erlenmeyer flasks) to an initial OD600 of 0.01 and incubated with shaking at 200 rpm at 37°C. When cultures reached OD600 = 0.05, FOS or inulin were added to a final concentration of 20 mg/ml and cultures were harvested for analysis 1 h later.

RNA Extraction, Library Preparation and RNA Sequencing

Total RNA was extracted with the TRI reagent (Ambion) using the manufacturer’s instructions. The RNase inhibitor RiboLock (Fermentas) was added to the samples and DNA was removed by treatment with DNase I (Fermentas). The integrity of the RNA samples was assessed with an Agilent 2100 Bioanalyzer (Agilent Technologies). Subsequently, the 23S, 16S, and 5S rRNAs were removed by subtractive hybridization using the MICROBExpress kit (Ambion) following the protocol reported by Gómez-Lozano et al. (2014). Removal of the rRNA was confirmed by an analysis with an Agilent 2100 Bioanalyzer (Agilent Technologies). Sequencing libraries were prepared using the TruSeq Stranded mRNA Sample Preparation kit (Illumina). After each step, the samples were validated using an Agilent 2100 Bioanalyzer (Agilent Technologies) and the final RNA concentration was measured using a Qubit 2.0 Fluorometer (Invitrogen). The libraries were sequenced using the Illumina HiSeq2000 platform with a paired-end protocol and read lengths of 100 nucleotides.

RNA-seq Analysis

The quality of sequenced reads was assessed using FastQC software, version 0.11.5 (Andrews and Fast, 2010). Single-end reads were aligned to the reference genome of P. aeruginosa PAO1 (GenBank accession number: AE004091.2) using SAMtools v 0.1.19 (Li et al., 2009). BAM files from SAM tools were used as input for the feature counts function (Liao et al., 2014) from the Rsubread package (Liao et al., 2013) of Bioconductor version 3.5 to generate a matrix of annotated genes with their corresponding raw counts. An average of 84.5% reads were successfully mapped to the reference genome. The count data were then analyzed to look for differential gene expression levels and statistical significance using DEseq2 (Love et al., 2014; Kimberly and Stephen, 2015).

The threshold to define differences in transcript levels was a statistical Log2 fold change. Genes were considered significantly differentially expressed when p-values were below 0.05.

RNA-Sequencing Data Registration Number

The sequence reads have been deposited in the GEO database under accession N°: GSE124468. The following secure token has been created to allow for the review of record GSE124468: glshocwuzvkprop.

Analysis of Gene Expression by Quantitative Real Time PCR

Quantitative real time-PCR experiments were performed to validate RNA-seq results. Total RNA was obtained by the TRI reagent® /BCP method (Ambion). One μg of RNA was retrotranscribed following the protocol provided in the manufacturer protocol (iScript BioRad, Alcobendas, Spain) and DNA sequences were amplified with a MX3005P real time PCR instrument (Stratagene) using the primers listed in Supplementary Table S3. The genes of interest were amplified by PCR using the Go Taq@qPCR Master Mix (Promega, Madison, WI, United States) as well as 1 μl of the cDNA template and the primers listed in Supplementary Table S3. Forty PCR cycles were conducted using an annealing temperature of 61°C. The cycle threshold values were normalized to that of the reference transcript, 16S RNA, and data were normalized to the control.

Generation of Mutants in Genes of the Genomic Island PA0643, PA0644, and PA0646

To generate the PA0643:Gm, PA0644:Gm, and PA0646:Gm mutants 656, 241, and 636 pb DNA fragments, respectively, covering the central part of the genes were amplified by PCR from P. aeruginosa PA01 genomic DNA. The resulting products were cloned into plasmid pMBL to yield plasmids pMBL:PA0643, pMBL:PA0644, and pMBL:PA0646. Subsequently, the resulting plasmids were digested with BamHI, which liberated the PA0643, PA0644, and PA0646 fragment. The plasmid pCHESI was also digested with BamHI, to liberate the gentamicin resistance gene (Gm) in order to ligate it with the three DNA fragments. The resulting chimeric DNA was cloned into pMBL digested with BamHI, to yield pMBL:PA0643ΩGm, pMBL:PA0644ΩGm and pMBL:PA0646ΩGm. The resulting plasmids were electroporated into P. aeruginosa PA01 for homologous double recombination. Mutant strains were selected on Gm plates and the correctness of the mutation was verified by Southern blotting (Sambrook et al., 1989; Molina-Fuentes et al., 2015).

Semi-Quantitative Determination of Biofilm Formation

Semi-quantitative determination of biofilm formation were performed as previously described (Christensen et al., 1985). P. aeruginosa PA0643, PA0644, and PA0646 mutants were tested in the biofilm-forming capacities in Minimum medium supplemented with 5 mM citrate. The determination of biofilm production was performed after 2, 4, and 6 h of growth by dissolving crystal violet from the biofilm with an ethanol-acetone mixture (70:30) and the absorbance measure at 590 nm.

Motility Assays

Assays were carried out to determine the effect of the PA0643, PA0644, and PA0646 deletion gene on swimming, twitching and swarming. For swimming assays, bacteria were placed with the help of a sterile tooth-pick at the center of plates containing a 5 mm layer of LB medium with 0.3% (w/v) Bacto agar, 0.2% casamino acids (w/v), and 30 mM glucose. Plates were incubated at 37°C for 24 h and the radial diffusion of bacteria, due to swimming, was inspected. To monitor twitching motility, bacteria were placed with a toothpick into a 2 mm thick layer containing 1.5% (w/v) Bacto agar, 0.2% (w/v) casamino acids, and 30 mM glucose. After incubation at 37°C for 24 h, the expansion of bacteria on the plate was observed. For swarming assays, 5 μl of an overnight culture of bacteria were placed in the center of swarm plates, which are made of 0.5% (w/v) Bacto agar supplemented with 0.2% (w/v) casamino acids and 30 mM glucose. Plates were incubated at 37°C for 24 h, followed by an inspection of the surface movement of the bacteria. All motility assays were performed in triplicate.

Statistical Analysis

All results are expressed as means from three cultures with the corresponding standard deviations. Data were analyzed for statistical significance using the one-way ANOVA analysis and a posteriori least significance test. All analyses were carried out with the SigmaStat 2.03 program (Jandel Corporation, San Rafael, CA, United States). Fitting of dose-response curves was done using Origin 7.0 (OriginLab Corporation, Northampton, MA, United States). Differences were considered significant at p < 0.05.

Results

FOS and Inulin Induce Differential Changes in Pseudomonas aeruginosa Transcript Levels

To understand the cellular response of P. aeruginosa PAO1 to FOS and inulin treatment, we conducted RNA-seq studies. Transcriptomic changes were determined in duplicate cultures grown in the absence and in the presence of either FOS or inulin at final concentrations of 20 mg/ml. Between 5,300,000 and up to 7,500,000 reads were obtained for inuline and FOS respectively, of which approximately 85% could be assigned to the 6,322 coding regions of the P. aeruginosa PAO1 reference genome (Table 1).

TABLE 1

SampleRaw readsMapped readsNot mapped readsPercent mapped
MM9-citrate74723856322981114940484.6%
Inulin5368865457535179351485.2%
FOS65983065580131101817584.6%

Statistics of RNA-seq data.

Shown are means from two replicates.

The heat map shown in Figure 1A illustrates genes with the most important alterations in transcript levels in the presence of FOS/inulin as compared to the control. For both compounds the number of genes with increased transcript levels were superior to those with decreased levels (see Figure 1B). FOS and inulin induced changes in the transcript level of 217 and 258 genes respectively, compared to the control to which no polysaccharide was added (Figure 2). Importantly, down changes in transcript levels of 57 and 83 genes were found to be specific for inulin or FOS, respectively (Figure 2A). Moreover, 201 and 134 genes showed an increase in transcript levels by inulin and FOS, respectively (Figure 2B) indicating that both compounds trigger different changes.

FIGURE 1

FIGURE 2

Supplementary Tables S1 and S2 show the list of genes for which the expression level significantly increased or decreased in the presence of 20 mg/ml of inulin (Supplementary Table S1) and FOS (Supplementary Table S2). Analysis of the expression pattern showed that only 22 genes had decreased levels in the presence of both compounds (Figure 2A and Table 2). Among these genes the most prominent changes were observed for genes involved in: (1) Organic acid transport such as PA1342 (aatj), which encodes a C4-dicarboxylate transport protein and PA1183 (dctA), (2) Central metabolism, like a PA0795 (prpC), which regulates a citrate synthase, PA2008 (fahA) that controls a fumarylacetoacetase, and PA1585 (sucA) encoding a 2- oxoglutatate dehydrogenase, (3) Oxidative stress such as superoxide dismutase PA4366 and (4) Virulence system like the Type VI secretion ATPase (PA0090). These genes were outnumbered by the genes for which both compounds caused an increase in transcript levels (Figure 2 and Table 3).

TABLE 2

Gene IdGeneProtein FunctionInulinFOS


log2 fold changep-value (10–6)log2 fold changep-value (10–6)
PA0090clpV1Type VI secretion ATPase−0.90.000−0.80.000
PA0296spuIGlutamylpolyamine synthetase−0.60.008−0.60.007
PA0795prpCCitrate synthase 2−1.10.001−0.90.002
PA1069ndHypothetical protein−0.70.000−0.50.003
PA1171sltB2Soluble lytic transglycolase−0.70.010−0.60.008
PA1183dctAC4-dicarboxylate transport protein−1.50.000−1.20.000
PA1342aatjProbable binding protein component of ABC transporter−1.00.000−1.10.000
PA1585sucA2-oxoglutarate dehydrogenase−0.50.008−0.60.001
PA1588sucCSuccinyl-CoA synthetase−0.70.000−0.60.002
PA1592ndHypothetical protein−0.90.000−0.80.001
PA1787acnBAconitate hydratase B−0.50.003−0.50.003
PA2007maiAMaleylacetatoacetate isomerase−1.10.000−0.70.003
PA2008fahAFumarylacetoacetase−1.10.000−1.10.000
PA2040pauA4Glutamylpolyamine synthetase−0.90.000−0.70.002
PA2247bkdA12-oxoisovalerate dehydrogenase−0.90.001−0.70.004
PA4055ribCRiboflavin synthase−0.70.009−0.70.005
PA4240rpsK30S ribosomal protein S11−0.70.003−1.00.000
PA4366sodBSuperoxide dismutase−0.70.000−0.70.000
PA4370icmPInsulin-cleaving metalloproteinase outer membrane protein−0.80.002−0.90.000
PA4578ndHypothetical protein−0.90.000−0.80.000
PA4824ndHypothetical protein−0.90.000−0.80.000
PA4825mgtAMg(2 +) transport ATPase P-type 2−0.90.000−0.80.000

Transcript levels that were reduced in the presence of both, inulin and FOS.

The above table shows the list of the significant down regulated genes and control with a log2 fold change cut off ≥ 0.5 by taking significant p-value < 0.05.

TABLE 3

Gene IdGeneProtein FunctionInulinFOS


Log2 fold changep-value (10–6)Log2 fold changep-value (10–6)
PA0003recFDNA replication and repair protein1.80.0001.20.000
PA0019defPeptide deformylase1.00.0000.80.000
PA0026plcBPhospholipase C0.70.0050.60.007
PA0408pilGTwitching motility protein0.80.0000.80.000
PA0576rpoDRNA polymerase sigma factor0.60.0000.70.000
PA0577dnaGDNA primase0.60.0020.50.003
PA0668tyrZTyrosyl-tRNA synthetase 20.90.0000.70.000
PA0691phdAPrevent-host-death protein A1.60.0001.30.000
PA0692pdtBPhosphate depletion regulated TPS partner B1.20.0001.10.000
PA0693exbB2Transport protein1.10.0001.10.000
PA07303-hydroxyacyl-CoA-acyl carrier protein transferase.0.80.0000.60.004
PA0762algURNA polymerase sigma factor0.60.0010.60.000
PA0768lepBSignal peptidase I0.70.0020.60.004
PA0782PutAProline dehydrogenase0.60.0020.50.006
PA0805Uncharacterized protein1.20.0001.20.000
PA0826Uncharacterized protein0.80.0000.70.000
PA0842Probable glycosyl transferase0.60.0070.60.005
PA0896aruFArginine N-succinyltransferase0.60.0010.50.001
PA0979Uncharacterized protein1.20.0001.00.000
PA1077flgBFlagellar basal body rod protein FlgB0.60.0070.60.004
PA1081flgFFlagellar basal-body rod protein FlgF0.90.0000.70.000
PA1084flglFlagellar P-ring protein0.60.0000.50.002
PA1327Serine protease0.90.0000.80.000
PA1382xqhBProbable type II secretion system protein0.60.0030.60.004
PA1414Uncharacterized protein1.90.0011.70.004
PA1606Uncharacterized protein0.90.0000.70.000
PA1608Probable chemotaxis transducer1.10.0000.80.000
PA1610fabABeta-hydroxydecanoyl-ACP dehydrase0.80.0000.80.000
PA1673Uncharacterized protein1.70.0001.30.000
PA1796folDCyclohydrolase0.60.0020.70.001
PA2022UDP-glucose 6-dehydrogenase1.00.0000.90.000
PA2428Uncharacterized protein1.10.0001.00.000
PA2548Uncharacterized protein0.80.0000.90.000
PA2667mvaUBiosynthetic process0.50.0120.60.001
PA2738himAIntegration host factor subunit alpha0.70.0000.80.000
PA2882Probable two-component sensor0.80.0011.00.000
PA2971yceDUncharacterized protein1.00.0000.60.003
PA3019uupProbable ATP-binding component of ABC transporter0.80.0000.60.002
PA3116Probable aspartate-semialdehyde dehydrogenase0.60.0030.50.008
PA3147wbpJProbable glycosyl transferase0.70.0010.70.000
PA3181edaA2-dehydro-3-deoxy-phosphogluconate aldolase1.10.0001.40.000
PA3183zwfGlucose-6-phosphate 1-dehydrogenase1.70.0002.00.000
PA3193glkGlucokinase0.60.0040.70.002
PA3194eddPhosphogluconate dehydratase1.50.0001.90.000
PA3195gapAGlyceraldehyde-3-phosphate dehydrogenase1.00.0011.10.000
PA3219Uncharacterized protein1.20.0001.30.000
PA3280oprOPyrophosphate-specific outer membrane porin1.10.0001.10.000
PA3296phoAAlkaline phosphatase0.60.0050.60.007
PA3305Uncharacterized protein2.30.0011.90.004
PA3351flgMTwo-component system0.60.0090.70.000
PA3382phnEPhosphonate transport protein0.60.0040.70.001
PA3383phnDBinding protein component of ABC phosphonate transporter0.70.0000.60.001
PA3384phnCPhosphonates import ATP-binding protein0.90.0000.90.000
PA3496ndUncharacterized protein0.50.0020.50.007
PA3560fruAPhosphotransferase system transporter1.10.0001.30.000
PA3561fruK1-phosphofructokinase1.80.0001.80.000
PA3562fruIPhosphotransferase system transporter enzyme I2.00.0002.00.000
PA3623ndUncharacterized protein0.70.0010.70.004
PA3744rimM16S rRNA processing protein0.80.0000.60.004
PA3746ffhSignal recognition particle protein0.60.0020.50.004
PA3903prfCPeptide chain release factor 30.90.0000.70.001
PA3990Uncharacterized protein1.30.0000.90.000
PA4255rpmC50S ribosomal protein L290.90.0000.80.000
PA4264rpsJ30S ribosomal protein S100.70.0010.60.004
PA4270rpoBDNA-directed RNA polymerase beta chain0.40.0090.50.003
PA4280birARegulation of transcription0.70.0000.70.000
PA4378InaAProtein of response to stimulus1.00.0000.60.000
PA4418ftsIPeptidoglycan D.D-transpeptidase1.10.0000.90.000
PA4420yabCUncharacterized protein0.50.0091.00.000
PA4421yabCUncharacterized protein1.20.0001.10.000
PA4432rpsI30S ribosomal protein S90.70.0120.80.000
PA4451yrbAUncharacterized protein0.70.0000.90.000
PA4462rpoNRNA polymerase sigma-54 factor0.90.0000.60.000
PA4520Probable chemotaxis transducer0.40.0090.50.003
PA4541lepALarge extracellular protease0.70.0000.60.000
PA4602glyA3Serine hydroxymethyltransferase1.00.0000.90.000
PA4690Uncharacterized protein0.50.0090.60.005
PA4723dksASuppressor protein1.00.0000.90.000
PA4741rpsO30S ribosomal protein S150.60.0010.90.000
PA4747secGSecretion protein0.60.0030.70.001
PA4844ctpLMethyl-accepting chemotaxis protein0.70.0010.60.002
PA4853fisPutative Fis-like DNA-binding protein0.70.0061.00.000
PA4945miaADelta 2-isopentenylpyrophosphate0.80.0000.60.004
PA4960serBProbable phosphoserine phosphatase0.90.0000.70.000
PA4961Uncharacterized protein0.70.0000.70.000
PA4963Uncharacterized protein0.80.0010.70.002
PA5013ilvEBranched-chain-amino-acid transferase0.70.0010.80.000
PA5015aceEPyruvate dehydrogenase0.70.0010.60.005
PA5042pilOType 4 fimbrial biogenesis protein1.00.0000.90.000
PA5045ponAPenicillin-binding protein 1A1.30.0001.00.000
PA5058phaC2Poly(3-hydroxyalkanoic acid) synthase 20.80.0001.00.000
PA5066hisIPhosphoribosyl-AMP cyclohydrolase0.60.0000.50.005
PA5152Probable ATP-binding component of ABC transporter0.60.0010.60.001
PA5170arcDArginine/ornithine antiporter0.70.0000.60.000
PA5208Uncharacterized protein0.50.0040.40.008
PA5235glpTGlycerol-3-phosphate transporter1.00.0000.90.000
PA5285sutAUncharacterized protein0.60.0030.60.002
PA5286yjbQUncharacterized protein0.70.0020.70.003
PA5301pauRPolyamine catabolic process0.70.0020.60.002
PA5315rpmG50S ribosomal protein L330.60.0020.60.001
PA5332crcCatabolite repression control protein1.10.0000.80.004
PA5348ndProbable DNA-binding protein0.60.0100.70.005
PA5367pstAPhosphate ABC transporter0.90.0051.20.000
PA5369pstSPhosphate ABC transporter0.80.0000.50.006
PA5435oadAProbable transcarboxylase activity0.60.0020.90.000

Transcript levels that were increased in the presence of both, inulin and FOS.

The above table shows the list of the significant up regulated genes and control with a log2 fold change cut off ≥ 0.5 by taking significant p-value < 0.05.

A significant number of these genes appear to be involved in sensing (transcriptional regulators, sensor kinases, and chemotaxis transducers), motility, glucose metabolism as well as control of transcription and protein synthesis (Figure 2 and Table 3).

Functional Analysis of Pseudomonas aeruginosa Transcriptome Following Exposure to FOS and Inulin

GO terms (WEGO) enrichment analyses were conducted to characterize the DEG (Differentially expressed genes) profiles and K-means clustering was performed to further investigate their biological function. We found that the differentially expressed genes can be classified into 32 categories that belonged to three gene ontology (GO) categories, i.e., the biological process, the cellular component or the molecular function (Figure 3). There were more genes classified into biological processes than the other two categories and most genes were predicted to have a binding function, as these genes are primarily involved in protein metabolism (Figure 3).

FIGURE 3

The over-expressed DEGs were assigned to 15 GO categories based on biological processes (Figure 3) and the results showed that the response to the stimulus, metabolic process, biological regulation, the establishment of localization and pigmentation were among the most highly represented groups in the biological process category in the presence of inulin or FOS. However, “biological adhesion” and “developmental process” showed a drastic decrease in the number of genes between inulin or FOS samples. While in the “locomotion process” most of the inhibited genes (43%) are annotated in FOS samples (Figure 3).

Furthermore, DEGs were assigned to seven GO categories based on cellular component and the result showed that “Cell” and “Cell part” are similar and highly represented groups for FOS and inulin samples (Figure 3). However, the “extracellular region” and the “organelle part” are lower and distinctly represented in the presence of inulin or FOS (Figure 3).

Genes with altered transcript levels could be grouped into 10 GO terms with different molecular functions of which the categories “antioxidant,” “binding,” “electron carrier,” “transcription regulator,” “structural molecular”, and “transcription regulator” were most populated (Figure 3). It is worth noting that, in the “molecular transducer” category a significantly higher number of genes were noted for inulin as compared to FOS. The individual genes that were classified into these different GO terms are provided in Supplementary Tables S1, S2.

Differential Gene Expression Pattern in the Presence of FOS

The differential expression analysis performed with DESeq2 in the presence of FOS showed that 83 gene transcript levels were reduced (Table 4), whereas 134 were increased (Figure 2 and Table 5). A large number of genes with reduced transcript levels (43%) were annotated as hypothetical proteins of uncharacterized functions (Table 4). We observed a decrease in the expression of genes related to (1) Metabolic pathways like citrate synthase (prpC), glutaminase-asparaginase (ansB), glutamylpolyamine synthetase (pauA4), and riboflavin synthase (ribC), (2) Transport systems such as PA0811 and PA1342 (aatj) (3) Translation cellular processes like several ribosomal proteins (rplQ, rpsD, rpsK, and rplK) and (4) Virulence such as PA0090 (clpV); PA0612 (ptrB), PA3866 (pyocin S4), and PA4370 (icmP) (see Table 4).

TABLE 4

Gene IDGeneProtein Functionlog2 Fold Changep-value (10–6)
PA0049Uncharacterized protein−1.20.001
PA0090clpV1Type VI secretion ATPase*−0.80.000
PA0296spuIGlutamylpolyamine synthetase−0.60.007
PA0612ptrBPositive regulation of cellular biosynthetic process−0.90.002
PA0613Uncharacterized protein−1.30.000
PA0614Uncharacterized protein−1.10.000
PA0615Uncharacterized protein−1.30.000
PA0616Uncharacterized protein−2.50.000
PA0617Uncharacterized protein−2.10.000
PA0618Uncharacterized protein−1.90.000
PA0619Uncharacterized protein−2.40.000
PA0620Uncharacterized protein−2.50.000
PA0621Uncharacterized protein−3.20.000
PA0622Uncharacterized protein−2.50.000
PA0623Uncharacterized protein−2.30.000
PA0624Uncharacterized protein−2.30.000
PA0625Uncharacterized protein−2.50.000
PA0626Uncharacterized protein−2.10.000
PA0627Uncharacterized protein−3.70.000
PA0628Uncharacterized protein−2.90.000
PA0629Uncharacterized protein−2.60.000
PA0630Uncharacterized protein−1.80.000
PA0631Uncharacterized protein−2.90.000
PA0632Uncharacterized protein−2.10.000
PA0633Uncharacterized protein−2.20.000
PA0634Uncharacterized protein−1.50.000
PA0635Uncharacterized protein−1.90.000
PA0636Uncharacterized protein−2.50.000
PA0637Uncharacterized protein−2.80.000
PA0638Uncharacterized protein−2.60.000
PA0639Uncharacterized protein−2.50.000
PA0640Uncharacterized protein−2.10.000
PA0641Uncharacterized protein−2.10.000
PA0642Uncharacterized protein−2.20.000
PA0643Uncharacterized protein−2.20.000
PA0644Uncharacterized protein−2.00.000
PA0645Uncharacterized protein−1.90.000
PA0646Uncharacterized protein−1.50.000
PA0647Uncharacterized protein−1.30.000
PA0795Uncharacterized protein−0.90.002
PA0807ampDN-acetylmuramoyl-L-alanine amidase−2.70.000
PA0809Transporter activity−1.70.000
PA0811Transmembrane transport−1.80.000
PA0812Uncharacterized protein−1.70.000
PA0908alpBResponse to antibiotic−2.00.000
PA0910alpDResponse to DNA damage stimulus−1.70.000
PA0911alpEResponse to DNA damage stimulus−1.40.000
PA0912Uncharacterized protein−2.40.000
PA1069Uncharacterized protein−0.50.003
PA1171sltB2Soluble lytic transglycolase−0.60.008
PA1183dctAC4-dicarboxylate transport protein−1.20.000
PA1337ansBGlutaminase-asparaginase−0.90.002
PA1342aatjProbable binding protein component of ABC transport−1.10.000
PA1585sucA2-oxoglutarate dehydrogenase−0.60.001
PA1588sucCSuccinyl-CoA synthetase−0.60.002
PA1592ndUncharacterized protein−0.80.001
PA1787acnBAconitrate hydratase B−0.50.003
PA2001atoBAcetyl-CoA acetyltransferase−1.00.002
PA2007maiAMaleylacetatoacetate isomerase−0.70.003
PA2008fahAFumarylacetoacetase−1.10.000
PA2040pauA4Glutamylpolyamine synthetase−0.70.002
PA2111Uncharacterized protein−1.10.000
PA2247bkdA12-oxoisovalerate dehydrogenase−0.70.004
PA2796talTransaldolase−0.80.004
PA3661Uncharacterized protein−1.00.001
PA3692lptFLipotoxon F−0.80.006
PA3866Pyocin S4−1.00.000
PA4055ribCRiboflavin synthase−0.70.005
PA4237rplQ50S ribosomal protein L17−0.60.005
PA4239rpsD30S ribosomal protein S4−0.60.001
PA4240rpsK30S ribosomal protein S11−1.00.000
PA4274rplk50S ribosomal protein L11−0.70.002
PA4366sodBSuperoxide dismutase−0.70.000
PA4370icmPInsulin-cleaving metalloproteinase outer membrane protein−0.90.000
PA4430probable cytochrome b−0.60.003
PA4578Uncharacterized protein−0.80.000
PA4774Uncharacterized protein−0.70.001
PA4823Uncharacterized protein−1.20.000
PA4824Uncharacterized protein−0.80.000
PA4825mgtAMg(2+) transport ATPase P-type 2−0.80.000
PA4826Uncharacterized protein−0.50.005
PA5149mviMUncharacterized protein−1.00.005
PA5169dctMC4-dicarboxylate transport−1.00.001

Genes with reduced transcript levels following exposure to FOS treatment.

The above table shows the list of the significant up regulated genes with a log2 fold change cut off ≥ 0.5 by taking significant p-value < 0.05.

TABLE 5

Gene IDGeneProteinLog2 fold Changep-value (10–6)
PA0003recFDNA replication and repair protein1.20.000
PA0019defPeptide deformylase0.80.000
PA0026plcBPhospholipase C0.60.007
PA0408pilGTwitching motility protein0.80.000
PA0576rpoDRNA polymerase sigma factor0.70.000
PA0577dnaGDNA primase0.50.003
PA0668tyrZTyrosyl-tRNA synthetase 20.70.000
PA0691phdAPrevent-host-death protein A1.30.000
PA0692pdtBPhosphate depletion regulated TPS partner B1.10.000
PA0693exbB2Transport protein1.10.000
PA0695Uncharacterized protein1.20.000
PA0715Uncharacterized protein0.60.007
PA07303-hydroxyacyl-CoA-acyl carrier protein transferase.0.60.004
PA0762algURNA polymerase sigma factor0.60.000
PA0768lepBSignal peptidase I0.60.004
PA0782putAProline dehydrogenase0.50.006
PA0805Uncharacterized protein1.20.000
PA0826Uncharacterized protein0.70.000
PA0842Probable glycosyl transferase0.60.005
PA0896aruFArginine N-succinyltransferase0.50.001
PA0952Uncharacterized protein1.10.001
PA0979Uncharacterized protein1.00.000
PA1077flgBFlagellar basal body rod protein FlgB0.60.004
PA1081flgFFlagellar basal-body rod protein FlgF0.70.000
PA1084flglFlagellar P-ring protein0.50.002
PA1327Serine protease0.80.000
PA1382xqhBProbable type II secretion system protein0.60.004
PA1414Uncharacterized protein1.70.004
PA1606Uncharacterized protein0.70.000
PA1608Probable chemotaxis transducer0.80.000
PA1610fabABeta-hydroxydecanoyl-ACP dehydrase0.80.000
PA1673Uncharacterized protein1.30.000
PA1796folDCyclohydrolase0.70.001
PA1803lonProtein secretion by the type III secretion system0.50.003
PA2022UDP-glucose 6-dehydrogenase0.90.000
PA2426pvdSSigma factor1.20.001
PA2428Uncharacterized protein1.00.000
PA2461Uncharacterized protein0.70.008
PA2548Uncharacterized protein0.90.000
PA2637nuoANADH dehydrogenase I0.60.004
PA2667mvaUBiosynthetic process0.60.001
PA2685vgrG4protein secretion system type VI0.50.005
PA2696probable transcriptional regulator1.00.004
PA2738himAIntegration host factor subunit alpha0.80.000
PA2756Uncharacterized protein0.70.000
PA2882Probable two-component sensor1.00.000
PA2971yceDUncharacterized protein0.60.003
PA3019uupProbable ATP-binding component of ABC transporter0.60.002
PA3116Probableaspartate-semialdehyde dehydrogenase0.50.008
PA3147wbpJProbable glycosyl transferase0.70.000
PA3161himIntegration host factor0.60.005
PA3181eda2-dehydro-3-deoxy-phosphogluconate aldolase1.40.000
PA3182pgl6-phosphogluconolactonase2.00.000
PA3183zwfGlucose-6-phosphate 1-dehydrogenase2.10.000
PA3190gltBComponent of ABC sugar transporter0.80.004
PA3192gltRTwo-component response regulator1.60.000
PA3193glkGlucokinase0.70.002
PA3194eddPhosphogluconate dehydratase1.90.000
PA3195gapAGlyceraldehyde-3-phosphate dehydrogenase1.10.000
PA3219Uncharacterized protein1.30.000
PA3262Peptidyl-prolyl cis-trans isomerase0.80.001
PA3280oprOPyrophosphate-specific outer membrane porin1.10.000
PA3296phoAAlkaline phosphatase0.60.007
PA3305Uncharacterized protein1.90.004
PA3345hptBHistidine phosphotransfer protein0.50.008
PA3351flgMTwo-component system0.70.000
PA3382phnEPhosphonate transport protein0.70.001
PA3383phnDBinding protein component of ABC phosphonate transporter0.60.001
PA3384phnCPhosphonates import ATP-binding protein0.90.000
PA3496Uncharacterized protein0.50.007
PA3560fruAPhosphotransferase system transporter1.30.000
PA3561fruK1-phosphofructokinase1.80.000
PA3562fruIPhosphotransferase system transporter enzyme I.2.00.000
PA3563Uncharacterized protein0.70.004
PA3623Uncharacterized protein0.60.002
PA3744rimM16S rRNA processing protein0.60.004
PA3746ffhSignal recognition particle protein0.50.004
PA3903prfCPeptide chain release factor 30.70.001
PA3990Uncharacterized protein0.90.000
PA4255rpmC50S ribosomal protein L291.10.000
PA4264rpsJ30S ribosomal protein S100.80.000
PA4270rpoBDNA-directed RNA polymerase beta chain0.90.000
PA4280birARegulation of transcription0.60.000
PA4335Uncharacterized protein1.10.001
PA4336Uncharacterized protein0.80.003
PA4378inaAProtein of response to stimulus0.60.004
PA4418ftsIPeptidoglycan D.D-transpeptidase0.50.003
PA4420yabCUncharacterized protein0.60.000
PA4421yabCUncharacterized protein0.90.000
PA4432rpsI30S ribosomal protein S90.60.005
PA4451yrbAUncharacterized protein0.90.000
PA4462rpoNRNA polymerase sigma-54 factor0.90.000
PA4475Uncharacterized protein0.70.001
PA4520Probable chemotaxis transducer0.60.002
PA4525pilAType 4 fimbrial precursor0.90.000
PA4541lepALarge extracellular protease1.00.000
PA4545comLOuter membrane lipoprotein0.60.003
PA4602glyA3Serine hydroxymethyltransferase0.60.004
PA4611Uncharacterized protein0.60.008
PA4690Uncharacterized protein1.10.000
PA4723dksASuppressor protein0.70.000
PA4741rpsO30S ribosomal protein S150.70.002
PA4747secGSecretion protein0.80.000
PA4844ctpLChemoreceptor for inorganic phosphate0.60.005
PA4853fisPutative Fis-like DNA-binding protein0.90.000
PA4941hflCProtease0.50.004
PA4944hfqMotilities and Quorum sensing0.60.001
PA4945miaADelta 2-isopentenylpyrophosphate1.00.000
PA4960serBProbable phosphoserine phosphatase0.60.003
PA4961Uncharacterized protein0.50.005
PA4963Uncharacterized protein0.60.001
PA5013ilvEBranched-chain-amino-acid transferase0.60.000
PA5015aceEPyruvate dehydrogenase0.40.008
PA5040pilQType IV pilus-dependent motility0.50.004
PA5042pilOType IV pilus-dependent motility0.90.000
PA5043pilNType IV pilus-dependent motility0.70.005
PA5045ponAPenicillin-binding protein 1A0.60.002
PA5058phaC2Poly(3-hydroxyalkanoic acid) synthase 20.70.003
PA5066hisIPhosphoribosyl-AMP cyclohydrolase0.60.002
PA5152Probable ATP-binding component of ABC transporter0.60.001
PA5170arcDArginine/ornithine antiporter0.80.004
PA5208Uncharacterized protein0.70.005
PA5235glpTGlycerol-3-phosphate transporter1.20.000
PA5255algQAlginate regulatory protein0.60.007
PA5285sutAUncharacterized protein0.50.006
PA5286yjbQUncharacterized protein0.70.000
PA5288glnKNitrogen regulatory protein0.60.003
PA5301pauRPolyamine catabolic process0.90.000
PA5315rpmG50S ribosomal protein L330.70.000
PA5332crcCatabolite repression control protein0.70.000
PA5348Probable DNA-binding protein0.70.001
PA5367pstAPhosphate ABC transporter0.70.001
PA5369pstSPhosphate ABC transporter0.70.000
PA5435oadAProbable transcarboxylase activity0.90.000

Genes with increased transcript levels following exposure to FOS treatment.

The above table shows the list of the significant up regulated genes with a log2 fold change cut off ≥ 0.5 by taking significant p-value < 0.05.

Surprisingly, in addition to increasing the expression of genes involved in different metabolic pathways necessary for bacterial growth, we found that transcript levels of many genes that are related to P. aeruginosa motility were increased in the presence of FOS (Table 5), exemplified by genes involved in twitching motility (pilG), components of the flagellar motor or chemoreceptors including CtpL that mediates specific taxis to inorganic phosphate – a key regulator of P. aeruginosa virulence (Zaborin et al., 2009; Bains et al., 2012). In the same manner, transcript levels of many genes associated within the glucose metabolism were also increased including genes eda, zwf, gapA, glk, edd, or gltR (Table 5) suggesting that P. aeruginosa can catabolize these compounds.

Effect of FOS on Virulence Related Gene Transcript Levels

All the DEGs were mapped to KO terms in the KEGG database to identify FOS modulated genes that play a role in bacterial virulence, motility, or sensitivity to antibiotics and the corresponding genes are provided in Table 6.

TABLE 6

Gene IDGeneProteinLog2 Fold ChangeFunctionReferences
PA0408pilGTwitching motility protein0.81Twitching motility and ChemotaxisDarzins, 1993; Darzins and Russell, 1997; Whitchurch et al., 2004
PA0668tyrZTyrosyl-tRNA synthetase 20.7Inhibit growth and biofilm formationWilliams-Wagner et al., 2015
PA0692pdtBPhosphate depletion regulated TPS partner B1.1Type V secretion systemFaure et al., 2014
PA0762algURNA polymerase sigma factor0.6Control expression of virulence genesStacey and Pritchett, 2016; Stacey et al., 2017
PA1077flgBFlagellar basal-body rod protein0.63Bacterial-type flagellum-dependent cell motilityGoodier and Ahmer, 2001
PA1081flgFFlagellar basal-body rod protein FlgF0.75Flagellar assemblyGoodier and Ahmer, 2001
PA1084flgIFlagellar P-ring protein0.54Flagellar assemblyGoodier and Ahmer, 2001
PA1382xqhBProbable type II secretion system protein0.6Type II secretion systemStover et al., 2000
PA1608Probable chemotaxis transducer0.8Chemotaxis system and biofilm formationSouthey-Pillig et al., 2005
PA2426pvdSSigma factor1.22Sigma factor activityTiburzi et al., 2008
PA3183zwfGlucose-6-phosphate 1-dehydrogenase2.13Carbohydrate metabolic pathwayUdaondo et al., 2018
PA3192gltRTwo component system1.6Carbohydrate metabolic and virulenceDaddaoua et al., 2014
PA3351flgMNegative regulator of flagellin synthesis FlgM0.73Flagellar assemblyGoodier and Ahmer, 2001
PA4520Chemotaxis transducer0.6Chemotaxis systemVictoria et al., 2003
PA4747secGSecretion protein0.7Sec secretory pathwayCrowther et al., 2015
PA4844ctpLChemoreceptor for inorganic phosphate0.6Chemotaxis to inorganic phosphateRico-Jiménez et al., 2016
PA5040pilQType 4 fimbrial biogenesis protein0.5Surface filaments involved in host colonizationDarzins, 1993; Darzins and Russell, 1997; Whitchurch et al., 2004
PA5042pilOType 4 fimbrial biogenesis protein0.9Surface filaments involved in adhesion cell, twitching motilityMartin et al., 1995; Leighton et al., 2018; Ayers et al., 2009
PA5043pilNType 4 fimbrial biogenesis protein0.7Surface filaments involved in host colonizationAyers et al., 2009
PA5045ponAPenicillin-binding protein 1A1.0ampR-β-lactamase modulationHandfield et al., 1997
PA5332crcCatabolite repression control protein0.8Virulence, Quorum SensingMilojevic et al., 2013; Chakravarthy et al., 2017
PA5435oadAProbable transcarboxylase activity0.9VirulenceBains et al., 2012
PA5369pstSPhosphate ABC transporter transporter control protein0.8VirulenceZaborin et al., 2009

Genes with increased transcript levels in response to FOS that are related to bacterial pathogenicity.

Noteworthy are the increases observed for transcript levels of PA0668 which encodes a TyrZ: Tyrosyl-tRNA synthetase2 that inhibits growth and biofilm formation (Williams-Wagner et al., 2015), genes of the pilMNOPQ operon, which are important for the pilus assembly system (T4P) and promote surface-associated attachment (Ayers et al., 2009; Tammam et al., 2013; McCallum et al., 2016) showed increased transcript levels like pilG (PA0408) (Log2 fold = 0.8); pilQ (PA5040) (0.5 Log2 fold); pilO (PA5042) (0.9 Log2 fold); pilN (PA5043) (0.7 Log2 fold); or different genes of the flg operon that encode proteins of the flagellar motor such as flgB (PA1077) (0.6 Log2 fold); flgF (PA1081) (0.7 Log2 fold); flgI (PA1084) (0.5 Log2 fold); and flgM (PA3351) (0.7 Log2 fold). Moreover, the transcript levels of three chemoreceptors were increased in the presence of FOS, of which two (PA1608, PA4520) are of unknown function, whereas PA4844 (ctpl) encodes a specific chemoreceptor for inorganic phosphate (Rico-Jiménez et al., 2016). In addition, the zwf1 gene encoding a glucose-6-phosphate dehydrogenase that is involved in P. aeruginosa virulence (Udaondo et al., 2018) showed much higher transcript levels (2.13 Log2 fold) in the presence of FOS. In the same manner, transcript levels of gltR encoding the response regulator of the GtrS/GltR two component system (TCS) were significantly increased (1.6 Log2 fold) (Table 6). This TCS was found to regulate the expression of toxA encoding the primary virulence factor exotoxin A (Udaondo et al., 2018).

However, the results (Table 7) show several virulence related genes with reduced transcript levels, such as PA0090 encoding the ClpV1 protein, involved in the type VI secretion system (Bönemann et al., 2009), or the PtrB component of the type III secretion system (TTSS) that coordinates TTSS repression and pyocin synthesis under DNA damage (Weihui and Shouguang, 2005). The latter observation agrees with the reduced transcript level of the gene (PA3866) encoding the pyocin S4 (Ameer et al., 2012).

TABLE 7

Gene IDGeneProteinFold changeFunctionReferences
PA0090clpVType VI secretion ATPase−0.84Biofilm formation and secretion system type VIBönemann et al., 2009
PA0296spuIGlutamylpolyamine synthetase−0.55Polyamine toxicityDong-Kwon and Chung-Dar, 2006
PA0612ptrBProtease−0.85Suppresses the Type III Secretion SystemWeihui and Shouguang, 2005
PA0807ampDN-acetylmuramoyl-L-alanine amidase−2.68β-lactam resistanceAmber and Nancy Hanson, 2008
PA0908alpBOuter membrane protein AlpB−1.98Cellular response to antibioticAlvarez-Ortega et al., 2010
PA1183dctAC4-dicarboxylate transport protein−1.23Growth processValentini et al., 2011
PA3692lptFLipotoxon F−0.78Integral component of membrane and survival factorHeath-Damron et al., 2009
PA3866Pyocin S4, soluble (S-type) pyocins−0.95Virulence factorAmeer et al., 2012
PA4370icmPInsulin-cleaving metalloproteinase outer membrane protein precursor−0.93PathogenicityChristian et al., 2015

Genes with decreased transcript levels in response to FOS that are related to bacterial pathogenicity.

In addition, the results shown in Table 7 reveal reduced transcript levels for PA3692 (lptF), encoding an outer membrane protein (alipotoxon), which plays a key role in P. aeruginosa survival under harsh environmental conditions, including lung colonization in patients with cystic fibrosis (Heath-Damron et al., 2009). Furthermore, the reduction in transcript levels for PA0807 (ampD) and PA0908 (alpB), encoding proteins involved in responses to antibiotics, or in PA0296, involved in polyamine toxicity, may indicate that FOS modulates sensitivity to antibiotics (Amber and Nancy Hanson, 2008; Shah and Swiatlo, 2008; Alvarez-Ortega et al., 2010) and polyamines (Dong-Kwon and Chung-Dar, 2006). These data have been confirmed by real time quantitative PCR (rt-qPCR) experiments (Table 8).

TABLE 8

Gene IDGeneProteinRelative expression levelsP-value
PA0807ampDN-acetylmuramoyl-L-alanine amidase−6.10.04
PA0908alpBOuter membrane protein AlpB−5.80.04
PA1183dctAC4-dicarboxylate transport protein−7.20.02
PA0296spuIGlutamylpolyamine synthetase−7.10.04
PA3866Pyocin S4Soluble (S-type) pyocins−10.70.01
PA4370icmPInsulin-cleaving metalloproteinase outer membrane−10.40.02
PA4844ctpLChemoreceptor for inorganic phosphate+ 0.650.09

Quantitative real time PCR experiments to quantify the effect of FOS on the transcript levels of genes that belong to the genomic island and that are related to bacterial pathogenicity in P. aeruginosa.

Experiments were conducted using P. aeruginosa cultures grown in the presence and absence of 20 mg/ml of FOS. The cycle threshold values were normalized to that of the reference transcript, 16S RNA, and data of relative expression levels were normalized to the control lacking FOS.

Moreover, FOS treatment resulted in lower transcript levels of the dctA gene (PA1183) which is associated with the normal growth of P. aeruginosa (Valentini et al., 2011) and of the icmP gene (PA4370) encoding an metalloproteinase outer membrane protein, which has been shown to degrade the plasminogen activator (Christian et al., 2015) and plays a key role in the Pseudomonas aeruginosa pathogenicity. These FOS mediated alterations in transcript levels have been confirmed by rt-qPCR studies (see Table 8). Altogether, data suggest that FOS acts as a signal molecule that modulates bacterial virulence through distinct signaling pathways.

Confirmation That FOS Reduces Expression of Structural Proteins of Secretion System III and VI

To confirm that FOS mediates changes in secretion system genes, we have conducted rt-qPCR experiments to determine the influence of FOS and inulin on the expression of 4 genes that encode proteins that are part of type III and VI secretion systems. The products of the pcrV and exsA genes control the activation of the type III secretion system (Lee et al., 2010), whereas the proteins encoded by hcp1 and vgrG1 are necessary for the type VI secretion system (Hachani et al., 2011).

We found that inulin caused a significant increase in pcrV and exsA transcript levels, whereas those of hcp1 and vgrG1 did not vary (Figure 4A). In contrast, the expression of exsA and hcp1 were dramatically down regulated by factors of approximately 20 and 7, respectively, in the presence of FOS (Figure 4B). FOS but not inulin down regulated the expression of two components of the type III and VI secretion system.

FIGURE 4

Identification of Genomics Islands Widely Repressed by FOS-Treatment in Pseudomonas aeruginosa PAO1

Due to their relevance to human health, extensive efforts have been made to study genomic islands, which are large genetic elements acquired through horizontal transmission (Juhas et al., 2009; Stephen and Julian, 2015; Mao and Lu, 2016).

Our data, using RNAseq sequence analysis, indicates the presence of a genomic island in PAO1 of ∼17 kb comprising 15 genes that had been inserted into the 3′-end of the PA0639 gene (Figure 5) through a phage encoded R2/F2 pyocin (Chang et al., 2005). Most of its genes were clearly repressed in the presence of FOS. Unfortunately, most of these genes code for proteins with unknown functions. Furthermore, in order to determine the biological role of this genomic island, various isogenic mutants were constructed and submitted to a phenotypic analysis that investigates changes in growth, biofilm formation, and motility. Interestingly, PA0643, PA0644, and PA0646 mutants showed reduced growth inhibition compared to the wild-type strain (Figure 6). In addition, while the PA0643 mutant strain did not cause any significant changes, the PA0644 and PA0646 isogenic mutant demonstrated a reduction in biofilm formation at 4 and 6 h (Figure 7). Moreover, PA0643, PA0644, and PA0646 mutants were tested for their ability to swim, swarm, and twitch and the results showed that the mutants exhibited differences in all three types of motility (Figure 8). While PA0643, PA0644, and PA0646 mutants caused the same reduced change in swarming motility, it was found that PA0644 and PA0646 mutants significantly inhibited (at least 50–60% of WT) the swimming motility. Interestingly, the twitching motility has been drastically reduced in the case of the PA0646 mutant (Figure 8). Markedly, this is the first study which shows that the deletion of PA0643, PA0644, and PA0646 genes are able to block P. aeruginosa swarming, swimming, and twitching motility. However, further studies are required to elucidate the function of these proteins.

FIGURE 5

FIGURE 6

FIGURE 7

FIGURE 8

Discussion

Various factors appear to be implicated in the ability of P. aeruginosa to cause health problems. While surface structures, including pili and the polysaccharide, seem to favor biofilm formation and adhesion of P. aeruginosa to host cells (Pollack, 1984/1992; Prince, 1992) promoting colonization, its exotoxins in combination with various secretion systems deteriorate the host’s defenses. The identification of signal molecules and the study of their corresponding molecular mechanism, which is associated with these processes, are of utmost interest.

Prebiotics have been shown to exert beneficial effects on human health by altering the intestinal microbiota and also by inhibiting the progression of some pathogenic strains (Knol et al., 2005), due to an indirect effect caused by the selective growth of host friendly bacteria. To our knowledge, antimicrobial properties have been described for a number of oligosaccharides (Daddaoua et al., 2006) and in a previous study, it was shown that FOS as a prebiotic had specific effects on P. aeruginosa, since it reduced growth, limited the formation of biofilm, impaired motility, and reduced the inflammatory response (Ortega-González et al., 2014). Although, inulin and FOS are structurally related oligosaccharides, they differ in chain length and both compounds can be used as a carbon and energy source for P. aeruginosa growth.

The present study demonstrates that FOS induces a number of important changes in P. aeruginosa transcript levels some of which are related to bacterial survival (Figure 1) and provides an initial insight into the corresponding molecular mechanisms. As shown in Figure 2, in the 162 genes with reduced transcript levels by FOS and inulin, only 13% of them were affected by both compounds. Similarly, of the 443 genes with increased levels only 24% of gene transcript levels were altered by both compounds. Therefore, these compounds can be considered as signal molecules; however, their molecular mechanisms remain unknown.

RNA-Seq and rt-qPCR based comparative RNA profiling of P. aeruginosa PAO1 in the presence of FOS or inulin, not only highlighted known functions required for survival metabolism, but revealed a decrease in transcript levels of genes associated with carbohydrate metabolism and growth such as PA1183 (dctA) which has been shown to be associated previously with bacterial growth (Valentini et al., 2011). Thus, the growth reduction may be due to a reduction in transcript levels of genes associated with carboxylic acid transport, carboxylic acid metabolism, and reduction in ribosomal proteins.

Furthermore, these studies revealed a decrease of spuI gene transcript levels (PA0296), confirmed by rt-qPCR (Table 8), which control the expression of polyamine toxicity and of pyocins (PA3866), which are virulence factors that are induced by DNA-damaging agents, such as UV light and mitomycin C (Dean-Scholl and Martin, 2008).

The current analysis clearly shows that the pathogenesis of P. aeruginosa in the presence of FOS is compromised due to a decrease in several virulence-associated genes; i.e., alpB (PA0908), a holin-like protein that is required for lysis and the icmP gene (PA4370), which has been shown to degrade plasminogen activator (Christian et al., 2015) and may play a role in P. aeruginosa pathogenicity (Tables 5, 8).

Secretion of exotoxins through type III secretion systems (T3SSs) (Filloux, 2011) are related to acute infections in P. aeruginosa, while type VI secretion systems are often associated with chronic infections and biofilm formation (Silverman et al., 2012).

Here we show by rt-qPCR that FOS lowers the transcript levels of exsA encoding a transcriptional activator of the secretion system type (T3SS) as well as those of a key protein necessary for the secretion system type VI (T6SS) function, encoded by the hcp gene (Figure 4).

Interestingly, the RNA seq analysis data coincide with a report that demonstrated that the repression of the ptrB gene (PA0612) is implicated in the regulation of the T3SS under DNA damage stress conditions (Weihui and Shouguang, 2005). In addition, this report demonstrates that a repression of clpV (PA0090) regulates the biofilm formation and T6SS (Table 5). Altogether, our study is consistent with the notion that the FOS mediated reduction in pathogenicity is mediated by the secretion systems III and VI.

Further, we obtained initial data suggesting that FOS modulates bacterial resistance to antibiotics, since FOS reduced the expression of ampD (PA0807) transcription levels which leads to the constitutive hyperproduction of the beta-lactamase AmpC and consequently to an increase of the β-lactam resistance (Lindberg et al., 1987). Furthermore, the data shows that FOS lowers transcript levels of alpB (PA0908) a gene product which is related to cell responses to antibiotics (Alvarez-Ortega et al., 2010).

The RNA seq analysis demonstrated the presence of an island with different genes of unknown function, whose expression was completely inhibited in the presence of FOS (Figure 5 and Table 4). The deletion of the PA0643, PA0644, and PA0646 genes caused alterations in bacterial growth (Figure 6), biofilm formation (Figure 7) and motility (Figure 8). The alteration of the transcript levels of this island is thus another possible mechanism by which FOS reduces bacterial pathogenesis.

Conclusion

FOS containing supplements are currently being used to prevent gastrointestinal infections (Yasuda et al., 2012), suggesting that it is a valid strategy to combat Pseudomonas infection by potentially including FOS in antimicrobial cocktails. The present study is a contribution to close the gap of knowledge that exists in the corresponding molecular mechanisms.

Statements

Data availability statement

All datasets generated for this study are included in the article/Supplementary Material.

Author contributions

JR-G, CS, and MG provided advice on experimental design. ZU and CS collected and assembled the data. AD designed the study, supervised and analyzed the data, and wrote the manuscript. TK and J-LR revised the manuscript. All authors reviewed and commented on the manuscript.

Funding

This work was supported by grants from the Spanish Ministry for Economy and Competitiveness (AGL2017-85270-R). CS is funded by the program Juan de la Cierva-Formación (FJCI-2015-23810).

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fmicb.2020.00202/full#supplementary-material

References

  • 1

    Alvarez-OrtegaC.WiegandI.OlivaresJ.HancockR. E.MartínezJ. L. (2010). Genetic determinants involved in the susceptibility of Pseudomonas aeruginosa to beta lactam antibiotics.Antimicrob. Agents Chemother.544159416710.1128/aac.00257-10

  • 2

    AmberS. J.Nancy HansonD. (2008). Role of ampD homologs in overproduction of AmpC in clinical isolates of Pseudomonas aeruginosa.Antimicrob. Agents Chemother.5239223927. 10.1128/AAC.00341-08

  • 3

    AmeerE.QingW.PierreC. (2012). The soluble pyocins S2 and S4 from Pseudomonas aeruginosa bind to the same FpvAI receptor.Microbiologyopen1268275. 10.1002/mbo3.27

  • 4

    AmerL. S.BishopB. M.Van HoekM. L. (2010). Antimicrobial and antibiofilm activity of cathelicidins and short, synthetic peptides against Francisella.Biochem. Biophys. Res. Commun.396246251. 10.1016/j.bbrc.2010.04.073

  • 5

    AndrewsS.FastQ. C. (2010). A Quality Control Tool for High Throughput Sequence Data. Available at: http://www.bioinformatics.babraham.ac.uk/projects/fastqc/

  • 6

    AnyanM. E.AmiriA.HarveyC. W.TierraG.Morales-SotoN.DriscollC. M.et al (2014). Type IV pili interactions promote intercellular association and moderate swarming of Pseudomonas aeruginosa.Proc. Natl. Acad. Sci. U.S.A.501801318018. 10.1073/pnas.1414661111

  • 7

    AyersM.SampaleanuL. M.TammamS.KooJ.HarveyH.HowellP. L.et al (2009). PilM/N/O/P proteins form an inner membrane complex that affects the stability of the Pseudomonas aeruginosa type IV pilus secretin.J. Mol. Biol.394128142. 10.1016/j.jmb.2009.09.034

  • 8

    BainsM.FernandezL.HancockR. E. (2012). Phosphate starvation promotes swarming motility and cytotoxicity of Pseudomonas aeruginosa.Appl. Environ. Microbiol.7867626768. 10.1128/AEM.01015-12

  • 9

    BertelliC.LairdM. R.WilliamsK. P.Simon Fraser University Research Computing Group, LauB. Y.HoadG.et al (2017). IslandViewer 4: expanded prediction of genomic islands for larger-scale datasets.Nucleic Acids Res.45W30W35.

  • 10

    BönemannG.PietrosiukA.DiemandA.ZentgrafH.MogkA. (2009). Remodelling of VipA/VipB tubules by ClpV-mediated threading is crucial for type VI protein secretion.EMBO J.28315325. 10.1038/emboj.2008.269

  • 11

    BosscherD.Van LooJ.FranckA. (2006). Inulin and oligofructose as prebiotics in the prevention of intestinal infections and diseases.Nutr. Res. Rev.19216226. 10.1017/S0954422407249686

  • 12

    BreidensteinE. B.de la Fuente-NunezC.HancockR. E. (2011). Pseudomonas aeruginosa: all roads lead to resistance.Trends Microbiol.19419426. 10.1016/j.tim.2011.04.005

  • 13

    BuhlM.PeterS.WillmannM. (2015). Prevalence and risk factors associated with colonization and infection of extensively drug-resistant Pseudomonas aeruginosa: a systematic review.Expert Rev. Anti Infect. Ther.1311591170. 10.1586/14787210.2015.1064310

  • 14

    CanoP. G.SantacruzA.TrejoF. M.SanzY. (2013). Bifidobacterium CECT 7765 improves metabolic and immunological alterations associated with obesity in high-fat diet-fed mice.Obesity (Silver Spring)2123102321. 10.1002/oby.20330

  • 15

    Capitán-CañadasF.OcónB.ArandaC. J.AnzolaA.SuárezM. D.ZarzueloA.et al (2016). Fructooligosaccharides exert intestinal anti-inflammatory activity in the CD4+ CD62L+ T cell transfer model of colitis in C57BL/6J mice.Eur. J. Nutr.5514451454. 10.1007/s00394-015-0962-6

  • 16

    Capitán-CañadasF.Ortega-GonzálezM.GuadixE.ZarzueloA.SuárezM. D.de MedinaF. S.et al (2013). Prebiotic oligosaccharides directly modulate proinflammatory cytokine production in monocytes via activation of TLR4.Mol. Nutr. Food Res.5810981110. 10.1002/mnfr.201300497

  • 17

    ChakravarthyS.ButcherB. G.LiuY.D’AmicoK.CosterM.FiliatraultM. J. (2017). Virulence of Pseudomonas syringae pv. tomato DC3000 is influenced by the catabolite repression control protein Crc.Mol. Plant Microbe Interact.30283294. 10.1094/MPMI-09-16-0196-R

  • 18

    ChangW.SmallD. A.ToghrolF.BentleyW. E. (2005). Microarray analysis of Pseudomonas aeruginosa reveals induction of pyocin genes in response to hydrogen peroxide.BMC Genomics6:115. 10.1186/1471-2164-6-115

  • 19

    ChristensenG. D.SimpsonW. A.YoungerJ. J.BaddourL. M.BarrettF. F.MeltonD. M.et al (1985). Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices.J. Clin. Microbiol.229961006. 10.1128/jcm.22.6.996-1006.1985

  • 20

    ChristianL.MelanieB.Chaves-MorenoD.AndreasO.ChristianH.StephanF.et al (2015). Metaproteomics approach to elucidate host and pathogen protein expression during catheter-associated urinary tract infections (CAUTIs).Mol. Cell. Proteomics149891008. 10.1074/mcp.M114.043463

  • 21

    CrowtherG. J.WellerS. M.JonesJ. C.WeaverT.FanE.Van VoorhisW. C.et al (2015). The bacterial sec pathway of protein export: screening and follow-up.J. Biomol. Screen.20921926. 10.1177/1087057115587458

  • 22

    DaddaouaA.Molina-SantiagoC.de la TorreJ.KrellT.RamosJ. L. (2014). GtrS and GltR form a two-component system: the central role of 2-ketogluconate in the expression of exotoxin A and glucose catabolic enzymes in Pseudomonas aeruginosa.Nucleic Acids Res.4276547663. 10.1093/nar/gku496

  • 23

    DaddaouaA.PuertaV.RequenaP.Martinez-FerezA.GuadixE.de MedinaF. S.et al (2006). Goat milk oligosaccharides are anti-inflammatory in rats with hapten-induced colitis.J. Nutr.136672676. 10.1093/jn/136.3.672

  • 24

    DarzinsA. (1993). The pilG gene product, required for Pseudomonas aeruginosa pilus production and twitching motility, is homologous to the enteric, single-domain response regulator CheY.J. Bacteriol.17559345944. 10.1128/jb.175.18.5934-5944.1993

  • 25

    DarzinsA.RussellM. A. (1997). Molecular genetic analysis of type-4 pilus biogenesis and twitching motility using Pseudomonas aeruginosa as a model system–a review.Gene192109115. 10.1016/s0378-1119(97)00037-1

  • 26

    Dean-SchollD.MartinD. W.Jr. (2008). Antibacterial efficacy of R-Type pyocins towards Pseudomonas aeruginosa in a murine peritonitis model.Antimicrob. Agents Chemother.5216471652. 10.1128/AAC.01479-07

  • 27

    Dong-KwonH.Chung-DarL. (2006). Polyamines increase antibiotic susceptibility in Pseudomonas aeruginosa.Antimicrob. Agents Chemother.501623162710.1128/aac.50.5.1623-1627.2006

  • 28

    DusejaA.ChawlaY. K. (2014). Obesity and NAFLD: the role of bacteria and microbiota.Clin. Liver Dis.185971

  • 29

    FaureL. M.GarvisS.De BentzmannS.BigotS. (2014). Characterization of a novel two-partner secretion system implicated in the virulence of Pseudomonas aeruginosa.Microbiology16019401952. 10.1099/mic.0.079616-0

  • 30

    FillouxA. (2011). Protein secretion systems in Pseudomonas aeruginosa: an essay on diversity, evolution. and function.Front. Microbiol.2:155. 10.3389/fmicb.2011.00155

  • 31

    FlemmingH. C.NeuT. R.WozniakD. J. (2007). The EPS matrix: the “house of biofilm cells”.J. Bacteriol.18979457947. 10.1128/jb.00858-07

  • 32

    FroebelL. K.JalukarS.LavergneT. A.LeeJ. T.DuongT. (2019). Administration of dietary prebiotics improves growth performance and reduces pathogen colonization in broiler chickens.Poult. Sci.9866686676. 10.3382/ps/pez537

  • 33

    GainesJ. M.CartyN. L.TiburziF.DavinicM.ViscaP.Colmer-HamoodJ. A.et al (2007). Regulation of the Pseudomonas aeruginosa toxA, regA and ptxR genes by the iron-starvation sigma factor PvdS under reduced levels of oxygen.Microbiology15342194233. 10.1099/mic.0.2007/011338-0

  • 34

    GibsonG. R.BeattyE. R.WangX. (1995). Cummings JH Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin.Gastroenterology108975982. 10.1016/0016-5085(95)90192-2

  • 35

    Gómez-LozanoM.MarvigR. L.TulstrupM. V. L.MolinS. (2014). Expression of antisense small RNAs in response to stress in Pseudomonas aeruginosa.BMC Genomics15:783. 10.1186/1471-2164-15-783

  • 36

    GoodierR. I.AhmerB. M. (2001). SirA orthologs affect both motility and virulence.J. Bacteriol.18322492258. 10.1128/jb.183.7.2249-2258.2001

  • 37

    HachaniA.LossiN. S.HamiltonA.JonesC.BlevesS. (2011). Type VI secretion system in Pseudomonas aeruginosa: secretion and multimerization of VgrG proteins.J. Biol. Chem.2861231712327. 10.1074/jbc.M110.193045

  • 38

    HandfieldJ.1GagnonL.DargisM.HuletskyA. (1997). Sequence of the ponA gene and characterization of the penicillin-binding protein 1A of Pseudomonas aeruginosa PAO1.Gene1994956. 10.1016/s0378-1119(97)00345-4

  • 39

    Heath-DamronF.NapperJ.Allison-TeterM.HongweiD. Yu. (2009). Lipotoxin F of Pseudomonas aeruginosa is an AlgU-dependent and alginate-independent outer membrane protein involved in resistance to oxidative stress and adhesion to A549 human lung epithelia.Microbiology15510281038. 10.1099/mic.0.025833-0

  • 40

    HoibyN.CiofuO.BjarnsholtT. (2010). Pseudomonas aeruginosa biofilms in cystic fibrosis.Future Microbiol.516631674. 10.2217/fmb.10.125

  • 41

    JuhasM. (2015). Pseudomonas aeruginosa essentials: an update on investigation of essential genes.Microbiology16120532060. 10.1099/mic.0.000161

  • 42

    JuhasM.Van der MeerJ. R.GaillardM.HardingR. M.HoodD. W.CrookD. W. (2009). FEMS genomic islands: tools of bacterial horizontal gene transfer and evolution.Microbiol. Rev.33376393. 10.1111/j.1574-6976.2008.00136.x

  • 43

    KimberlyR. K.StephenM. B. (2015). RNA sequencing and analysis.Cold Spring Harb. Protoc.11951969.

  • 44

    KlausenM.HeydornA.RagasP.LambertsenL.Aaes-JorgensenA. (2003). Biofilm formation by Pseudomonas aeruginosa wild type, flagella and type IV pili mutants.Mol. Microbiol.4815111524. 10.1046/j.1365-2958.2003.03525.x

  • 45

    KnolJ.BoehmG.LidestriM.NegrettiF.JelinekJ. (2005). Increase of faecal bifidobacteria due to dietary oligosaccharides induces a reduction of clinically relevant pathogen germs in the faeces of formula-fed preterm infants.Acta Paediatr. Suppl.943133. 10.1111/j.1651-2227.2005.tb02152.x

  • 46

    LattimerJ. M.HaubM. D. (2010). Effects of dietary fiber and its components on metabolic health.Nutrients212661289. 10.3390/nu2121266

  • 47

    LeeP. C.StopfordC. M.SvensonA. G.RietschA. (2010). Control of effector export by the Pseudomonas aeruginosa type III secretion proteins PcrG and PcrV.Mol. Microbiol.75924941. 10.1111/j.1365-2958.2009.07027.x

  • 48

    LeightonT. L.MokM. C.JunopM. S.HowellP. L.BurrowsL. L. (2018). Conserved, unstructured regions in Pseudomonas aeruginosa PilO are important for type IVa pilus function.Sci. Rep.8:2600. 10.1038/s41598-018-20925-w

  • 49

    LiH.HandsakerB.WysokerA.FennellT.RuanJ.HomerN.et al (2009). The sequence alignment/map format and samtools.Bioinformatics2520782079. 10.1093/bioinformatics/btp352

  • 50

    LiaoY.SmythG. K.ShiW. (2013). The Subread aligner: fast accurate and scalable read mapping by seed-and-vote.Nucleic Acids Res.41:e108. 10.1093/nar/gkt214

  • 51

    LiaoY. G. K.SmythG. K.ShiW. (2014). Feature counts: an efficient general purpose program for assigning sequence reads to genomic features.Bioinformatics30923930. 10.1093/bioinformatics/btt656

  • 52

    LindbergF.LindquistS.NormarkS. (1987). Inactivation of the ampD gene causes semiconstitutive overproduction of the inducible Citrobacter freundii beta-lactamase.J. Bacteriol.16919231928. 10.1128/jb.169.5.1923-1928.1987

  • 53

    LoveM. I.HuberW.AndersS. (2014). Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.Genome Biol.15:550.

  • 54

    LynchJ. P.IIIZhanelG. G.ClarkN. M. (2017). Emergence of antimicrobial resistance among Pseudomonas aeruginosa: implications for therapy.Semin. Respir. Crit. Care Med.38326345. 10.1055/s-0037-1602583

  • 55

    MahT. F.PittsB.PellockB.WalkerG. C. (2003). A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance.Nature426306310. 10.1038/nature02122

  • 56

    MaoJ.LuT. (2016). Population-dynamic modeling of bacterial horizontal gene transfer by natural transformation.Biophys. J.110258268. 10.1016/j.bpj.2015.11.033

  • 57

    MartinP. R.WatsonA. A.McCaulT. F.MattickJ. S. (1995). Characterization of a five-gene cluster required for the biogenesis of type 4 fimbriae in Pseudomonas aeruginosa.Mol. Microbiol.16497508. 10.1111/j.1365-2958.1995.tb02414.x

  • 58

    McCallumM.TammamS.LittleD. J.RobinsonH.KooJ.ShahM.et al (2016). PilN binding modulates the structure and binding partners of the Pseudomonas aeruginosa type IVa pilus protein pilm.J. Biol. Chem.2911100311015. 10.1074/jbc.M116.718353

  • 59

    MilojevicT.GrishkovskayaI.SonnleitnerE.Djinovic-CarugoK.BläsiU. (2013). The Pseudomonas aeruginosa catabolite repression control protein Crc is devoid of RNA binding activity.PLoS One8:e64609. 10.1371/journal.pone.0064609

  • 60

    MiuraK.OhnishiH. (2014). Role of gut microbiota and toll-like receptors in nonalcoholic fatty liver disease.World J. Gastroenterol.2073817391. 10.3748/wjg.v20.i23.7381

  • 61

    Miyoshi-AkiyamaT.TadaT.OhmagariN.Viet HungN.TharavichitkulP.PokhrelB. M.et al (2017). Emergence and spread of epidemic multidrug-resistant Pseudomonas aeruginosa.Genome Biol. Evol.932383245. 10.1093/gbe/evx243

  • 62

    Molina-FuentesÁ.PachecoD.MarínP.PhilippB.SchinkB.MarquésS. (2015). Identification of the gene cluster for the anaerobic degradation of 3,5-Dihydroxybenzoate (α-Resorcylate) in Thauera aromatica strain AR-1.Appl. Environ. Microbiol.8172017214. 10.1128/AEM.01698-15

  • 63

    NatividadJ. M.VerduE. F. (2012). Modulation of intestinal barrier by intestinal microbiota: pathological and therapeutic implications.Pharmacol. Res.694251. 10.1016/j.phrs.2012.10.007

  • 64

    OharaT.ItohK. (2003). Significance of Pseudomonas aeruginosa colonization of the gastrointestinal tract.Intern. Med.4210721076. 10.2169/internalmedicine.42.1072

  • 65

    Ortega-GonzálezM.Sánchez de MedinaF.Molina-SantiagoC.López-PosadasR.PachecoD.KrellT.et al (2014). Fructooligosacharides reduce Pseudomonas aeruginosa PAO1 pathogenicity through distinct mechanisms.PLoS One22:e85772. 10.1371/journal.pone.0085772

  • 66

    Ortiz-CastroR.Pelagio-FloresR.Méndez-BravoA.Ruiz-HerreraL. F.Campos-GarcíaJ.López-BucioJ. (2014). Pyocyanin, a virulence factor produced by Pseudomonas aeruginosa, alters root development through reactive oxygen species and ethylene signaling in Arabidopsis.Mol. Plant Microbe Interact.27364378. 10.1094/MPMI-08-13-0219-R

  • 67

    PollackM. (1984/1992). The virulence of Pseudomonas aeruginosa.Rev. Infect. Dis.6(Suppl. 3)S617-S626.

  • 68

    PrinceA. (1992). Adhesins and receptors of Pseudomonas aeruginosa associated with infection of the respiratory tract.Microb. Pathog.13251260. 10.1016/0882-4010(92)90035-m

  • 69

    Rico-JiménezM.Reyes-DariasJ.-A.OrtegaÁ.PeñaA. I. D.MorelB.TinoK. (2016). Two different mechanisms mediate chemotaxis to inorganic phosphate in Pseudomonas aeruginosa.Sci. Rep.6:28967. 10.1038/srep28967

  • 70

    SambrookJ.FritschE. F.ManiatisT. (1989). Molecular Cloning: A Laboratory Manual, 2nd Edn.Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.

  • 71

    Sánchez de MedinaF.Ortega-GonzálezM.González-PérezR.Capitán-CañadasF.Martínez-AugustinO. (2013). Host-microbe interactions: the difficult yet peaceful coexistence of the microbiota and the intestinal mucosa.Br. J. Nutr.109S12S20

  • 72

    ShahP.SwiatloE. (2008). A multifaceted role for polyamines in bacterial pathogens.Mol. Microbiol.68416. 10.1111/j.1365-2958.2008.06126.x

  • 73

    SilvermanJ. M.BrunetY. R.CascalesE.MougousJ. D. (2012). Structure and regulation of the type VI secretion system.Annu. Rev. Microbiol.66453472. 10.1146/annurev-micro-121809-151619

  • 74

    Southey-PilligC. J.DaviesD. G.SauerK. (2005). Characterization of temporal protein production in Pseudomonas aeruginosa biofilms.J. Bacteriol.18781148126. 10.1128/jb.187.23.8114-8126.2005

  • 75

    StaceyS. D.PritchettC. L. (2016). Pseudomonas aeruginosa AlgU contributes to posttranscriptional activity by increasing rsmA expression in a mucA22 Strain.J. Bacteriol.19818121826. 10.1128/JB.00133-16

  • 76

    StaceyS. D.WilliamsD. A.PritchettC. L. (2017). The Pseudomonas aeruginosa two-component regulator AlgR directly activates rsmA expression in a phosphorylation independent manner.J Bacteriol.199:e00048-17. 10.1128/JB.00048-17

  • 77

    StephenD. B.JulianP. (2015). Genomic perspectives on the evolution and spread of bacterial pathogens.Proc. Biol. Sci.282:20150488. 10.1098/rspb.2015.0488

  • 78

    StoodleyP.SauerK.DaviesD. G.CostertonJ. W. (2002). Biofilms as complex differentiated communities.Annu. Rev. Microbiol.56187209. 10.1146/annurev.micro.56.012302.160705

  • 79

    StoverC. K.PhamX. Q.ErwinA. L.MizoguchiS. D.WarrenerP.HickeyM. J.et al (2000). Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen.Nature406959964.

  • 80

    TammamS.SampaleanuL. M.KooJ.ManoharanK.DaubarasM.BurrowsL. L.et al (2013). PilMNOPQ from the Pseudomonas aeruginosa type IV pilus system form a transenvelope protein interaction network that interacts with PilA.J. Bacteriol.19521262135. 10.1128/JB.00032-13

  • 81

    TaylorP. K.YeungA. T. Y.HancockR. E. W. (2014). Antibiotic resistance in Pseudomonas aeruginosa biofilms: towards the development of novel anti-biofilm therapies.J. Biotechnol.191121130. 10.1016/j.jbiotec.2014.09.003

  • 82

    TiburziF.ImperiF.ViscaP. (2008). Intracellular levels and activity of PvdS, the major iron starvation sigma factor of Pseudomonas aeruginosa.Mol. Microbiol.67213227. 10.1111/j.1365-2958.2007.06051.x

  • 83

    UdaondoZ.RamosJ.SeguraA.KrellT.DaddaouaA. (2018). Regulation of carbohydrate degradation pathways in Pseudomonas involves a versatile set of transcriptional regulators.Microb. Biotechnol.11442454. 10.1111/1751-7915.13263

  • 84

    ValentiniM.StorelliN.LapougeK. (2011). Identification of C4-Dicarboxylate transport systems in Pseudomonas aeruginosa PAO1.J. Bacteriol.19343074316. 10.1128/jb.05074-11

  • 85

    VictoriaE. W.DanielB.LucianoP.BrooksA. I.IglewskiB. H. (2003). Microarray analysis of Pseudomonas aeruginosa quorum-sensing regulons: effects of growth phase and environment.J. Bacteriol.18520802095. 10.1128/jb.185.7.2080-2095.2003

  • 86

    Von KlitzingE.BereswillS.HeimesaatM. M. (2017). Multidrug-resistant Pseudomonas aeruginosa induce systemic pro-inflammatory immune responses in colonized mice.Eur. J. Microbiol. Immunol.7200209. 10.1556/1886.2017.00022

  • 87

    WeihuiW.ShouguangJ. (2005). PtrB of Pseudomonas aeruginosa suppresses the type III secretion system under the stress of DNA damage.J. Bacteriol.18760586068. 10.1128/jb.187.17.6058-6068.2005

  • 88

    WhitchurchC. B.LeechA. J.YoungM. D.KennedyD.SargentJ. L.BertrandJ. J.et al (2004). Characterization of a complex chemosensory signal transduction system which controls twitching motility in Pseudomonas aeruginosa.Mol. Microbiol.52873893. 10.1111/j.1365-2958.2004.04026.x

  • 89

    WHO (2017). Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery and Development of New Antibiotics. Available at: http://www.who.int/medicines/publications/global-priority-list-antibiotic-resistant-bacteria/en/

  • 90

    Williams-WagnerR. N.GrundyF. J.RainaM.IbbaM.HenkinT. M. (2015). The Bacillus subtilis tyrZ gene encodes a highly selective tyrosyl-tRNA synthetase and is regulated by a MarR regulator and T box riboswitch.J. Bacteriol.19716241631. 10.1128/JB.00008-15

  • 91

    YasudaA.InoueK.SanbongiC.YanagisawaR.IchinoseT. (2012). Dietary supplementation with fructooligosaccharides attenuates allergic peritonitis in mice.Biochem. Biophys. Res. Commun.422546550. 10.1016/j.bbrc.2012.05.007

  • 92

    ZaborinA.RomanowskiK.GerdesS.HolbrookC.LepineF.LongJ.et al (2009). Red death in Caenorhabditis elegans caused by Pseudomonas aeruginosa PAO1.Proc. Natl. Acad. Sci. U.S.A.10663276332. 10.1073/pnas.0813199106

Summary

Keywords

RNA sequencing, rt-qPCR, adhesion, developmental process, molecular transducer, pathogenicity

Citation

Rubio-Gómez JM, Santiago CM, Udaondo Z, Garitaonaindia MT, Krell T, Ramos J-L and Daddaoua A (2020) Full Transcriptomic Response of Pseudomonas aeruginosa to an Inulin-Derived Fructooligosaccharide. Front. Microbiol. 11:202. doi: 10.3389/fmicb.2020.00202

Received

26 November 2019

Accepted

28 January 2020

Published

20 February 2020

Volume

11 - 2020

Edited by

Eric Houdeau, INRA UMR1331 Toxicologie Alimentaire, France

Reviewed by

Jesús Muñoz-Rojas, Meritorious Autonomous University of Puebla, Mexico; Mariam Sahrawy Barragan, Spanish National Research Council (CSIC), Spain

Updates

Copyright

*Correspondence: Abdelali Daddaoua,

These authors have contributed equally to this work

This article was submitted to Microbial Symbioses, a section of the journal Frontiers in Microbiology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics